KRAS and cancer: Here, we found that the KRAS-G12D mutation rewires amino acid metabolism, so our findings support the notion that activation of RAS mutants is a double-edged sword: it can promote cell proliferation, but it can also induce metabolic vulnerabilities during cancer progression.